Streetbeat News

Analyst Ratings

AMAM

Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Ambrx Biopharma (NASDAQ:AMAM) and maintained a $25 price target.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 1:08 pm

ROIV

Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Roivant Sciences (NASDAQ:ROIV) and maintained a $15 price target.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 1:07 pm

BAH

Wells Fargo analyst Matthew Akers has maintained an Overweight rating on Booz Allen Hamilton (NYSE:BAH) but lowered the price target from $140 to $126.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 1:07 pm

PFE

Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Pfizer (NYSE:PFE) and maintained a $75 price target.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 1:06 pm

INFY

Wedbush analyst Moshe Katri has reiterated an Outperform rating on Infosys (NYSE:INFY) and maintained a $22 price target.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 1:03 pm

PLTR

Wedbush analyst Daniel Ives has reiterated an 'Outperform' rating on Palantir Technologies (NYSE:PLTR) and maintained a $25 price target.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 1:01 pm

LMT

In the last quarter, Lockheed Martin (NYSE:LMT) received mixed analyst ratings with 1 bullish, 1 somewhat bullish, 3 indifferent, and 1 somewhat bearish. The average 12-month price target for the company, according to 6 analysts, is $498.67, a decrease of 4.8% from the previous average of $523.80.

Portfolio Pulse from Benzinga Insights

September 18, 2023 | 1:01 pm

ARGX

Over the past 3 months, 20 analysts have published their opinion on argenx (NASDAQ:ARGX) stock. The average price target for argenx is $551.95, with a high of $609.00 and a low of $436.00. The average price target has increased by 7.86% over the past month. The majority of the ratings are bullish.

Portfolio Pulse from Benzinga Insights

September 18, 2023 | 1:01 pm

VERX

Over the last quarter, Vertex (NASDAQ:VERX) has received a mix of analyst ratings, with 1 bullish, 2 somewhat bullish, and 3 indifferent. The average price target among these analysts is $23.83, which is higher than the current price of $20.69, implying an upside. The average price target has increased by 5.12% over the past month.

Portfolio Pulse from Benzinga Insights

September 18, 2023 | 1:01 pm

WNS

Over the last quarter, WNS (Hldgs) (NYSE:WNS) has received six analyst ratings, all of which are either bullish or somewhat bullish. The average 12-month price target for the stock is $97.67, representing a 7.27% decrease from the previous average price target of $105.33.

Portfolio Pulse from Benzinga Insights

September 18, 2023 | 1:01 pm